China’s Economy, Retail Rundown and the Shrimp Indicator 6/20/23
Power Lunch
00:00
Eli Lilly Acquiring Diced Therapeutics for $2.4 Billion
Eli Lilly announces its buying diced therapeutics in a $2.4 billion all cash deal. Dice specializes in oral therapeutic drugs for autoimmune diseases. Emily shares, which are already having a huge year, up another 1%. Dice up 37%. We'll trade the news in three-stock lunch next.
Play episode from 39:08
Transcript
